Grange David L

Grange David L is listed in filings as Director at Tonix Pharmaceuticals Holding Corp.. This profile follows SEC Form 4 activity through May 14, 2026, including 2 public disclosures. Recent filings connect the profile to Tonix Pharmaceuticals Holding Corp. (TNXP). The current snapshot covers public activity from May 15, 2025 to May 14, 2026. Reported amounts are shown as $301.5K to $201.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.